Leyla Alaton Günyeli
Director/Board Member bei ALARKO HOLDING
Vermögen: 286 Mio $ am 31.03.2024
Profil
Leyla Alaton Günyeli is currently serving as a Non-Independent Non-Executive Director at Alarko Holding AS since 2002.
She is also a Director at Attas Alarko Turistik Tesisler AS and the President of Alvimedica ApS.
Ms. Alaton Günyeli completed her undergraduate degree at Fairleigh Dickinson University and her graduate degree at New York University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALARKO HOLDING A.S.
16,27% | 20.09.2023 | 70 776 560 ( 16,27% ) | 286 Mio $ | 31.03.2024 |
Aktive Positionen von Leyla Alaton Günyeli
| Unternehmen | Position | Beginn |
|---|---|---|
| ALARKO HOLDING | Director/Board Member | 29.03.2002 |
Alvimedica ApS
 Alvimedica ApS Medical SpecialtiesHealth Technology Alvimedica ApS manufactures coronary stents, balloon catheters and diagnostic and guiding catheters. The firm's projects include renal and cranial intravascular stents. It is also working on bioabsorbable stents which are completely absorbed into the body. The company was founded by Ishak Alaton in 2007 and is headquartered Istanbul, Turkey. | President | - |
| Attas Alarko Turistik Tesisler AS | Director/Board Member | - |
Ausbildung von Leyla Alaton Günyeli
| Fairleigh Dickinson University | Undergraduate Degree |
| New York University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALARKO HOLDING | Finance |
| Private Unternehmen | 2 |
|---|---|
Alvimedica ApS
Alvimedica ApS Medical SpecialtiesHealth Technology Alvimedica ApS manufactures coronary stents, balloon catheters and diagnostic and guiding catheters. The firm's projects include renal and cranial intravascular stents. It is also working on bioabsorbable stents which are completely absorbed into the body. The company was founded by Ishak Alaton in 2007 and is headquartered Istanbul, Turkey. | Health Technology |
| Attas Alarko Turistik Tesisler AS |
